108 related articles for article (PubMed ID: 9401921)
1. Common and differential recognition of structural features in synthetic peptides by the catalytic domain and the Src-homology 2 (SH2) domain of pp60c-src.
Johnson TM; Perich JW; Bjorge JD; Fujita DJ; Cheng HC
J Pept Res; 1997 Nov; 50(5):365-71. PubMed ID: 9401921
[TBL] [Abstract][Full Text] [Related]
2. Purification of bovine thymus cytosolic C-terminal Src kinase (CSK) and demonstration of differential efficiencies of phosphorylation and inactivation of p56lyn and pp60c-src by CSK.
Cheng HC; Bjorge JD; Aebersold R; Fujita DJ; Wang JH
Biochemistry; 1996 Sep; 35(36):11874-87. PubMed ID: 8794770
[TBL] [Abstract][Full Text] [Related]
3. Binding of the Src SH2 domain to phosphopeptides is determined by residues in both the SH2 domain and the phosphopeptides.
Bibbins KB; Boeuf H; Varmus HE
Mol Cell Biol; 1993 Dec; 13(12):7278-87. PubMed ID: 7504171
[TBL] [Abstract][Full Text] [Related]
4. Selective binding of activated pp60c-src by an immobilized synthetic phosphopeptide modeled on the carboxyl terminus of pp60c-src.
Roussel RR; Brodeur SR; Shalloway D; Laudano AP
Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10696-700. PubMed ID: 1720546
[TBL] [Abstract][Full Text] [Related]
5. Examination of the dephosphorylation reactions catalyzed by pp60c-src tyrosine kinase explores the roles of autophosphorylation and SH2 ligand binding.
Boerner RJ; Kassel DB; Edison AM; Knight WB
Biochemistry; 1995 Nov; 34(45):14852-60. PubMed ID: 7578095
[TBL] [Abstract][Full Text] [Related]
6. Regulation of the cellular src protein tyrosine kinase: interactions of the carboxyl terminal sequences residing between the kinase domain and tyrosine-527.
Cobb BS; Parsons JT
Oncogene; 1993 Nov; 8(11):2897-903. PubMed ID: 7692368
[TBL] [Abstract][Full Text] [Related]
7. Role of electrostatic interactions in SH2 domain recognition: salt-dependence of tyrosyl-phosphorylated peptide binding to the tandem SH2 domain of the Syk kinase and the single SH2 domain of the Src kinase.
Grucza RA; Bradshaw JM; Mitaxov V; Waksman G
Biochemistry; 2000 Aug; 39(33):10072-81. PubMed ID: 10955995
[TBL] [Abstract][Full Text] [Related]
8. Purification and characterization of a pp60c-src-related tyrosine kinase that effectively phosphorylates a synthetic peptide derived from p34cdc2.
Litwin CM; Cheng HC; Wang JH
J Biol Chem; 1991 Feb; 266(4):2557-66. PubMed ID: 1703531
[TBL] [Abstract][Full Text] [Related]
9. In vitro phosphorylation of the epidermal growth factor receptor autophosphorylation domain by c-src: identification of phosphorylation sites and c-src SH2 domain binding sites.
Lombardo CR; Consler TG; Kassel DB
Biochemistry; 1995 Dec; 34(50):16456-66. PubMed ID: 8845374
[TBL] [Abstract][Full Text] [Related]
10. Regulation of c-Src tyrosine kinase activity by the Src SH2 domain.
Liu X; Brodeur SR; Gish G; Songyang Z; Cantley LC; Laudano AP; Pawson T
Oncogene; 1993 May; 8(5):1119-26. PubMed ID: 7683128
[TBL] [Abstract][Full Text] [Related]
11. Dissection of the energetic coupling across the Src SH2 domain-tyrosyl phosphopeptide interface.
Lubman OY; Waksman G
J Mol Biol; 2002 Feb; 316(2):291-304. PubMed ID: 11851339
[TBL] [Abstract][Full Text] [Related]
12. Correlation of the phosphorylation states of pp60c-src with tyrosine kinase activity: the intramolecular pY530-SH2 complex retains significant activity if Y419 is phosphorylated.
Boerner RJ; Kassel DB; Barker SC; Ellis B; DeLacy P; Knight WB
Biochemistry; 1996 Jul; 35(29):9519-25. PubMed ID: 8755732
[TBL] [Abstract][Full Text] [Related]
13. Recognition of a high-affinity phosphotyrosyl peptide by the Src homology-2 domain of p56lck.
Eck MJ; Shoelson SE; Harrison SC
Nature; 1993 Mar; 362(6415):87-91. PubMed ID: 7680435
[TBL] [Abstract][Full Text] [Related]
14. Enhanced phosphorylation of Src family kinase substrates containing SH2 domain binding sites.
Pellicena P; Stowell KR; Miller WT
J Biol Chem; 1998 Jun; 273(25):15325-8. PubMed ID: 9624111
[TBL] [Abstract][Full Text] [Related]
15. Autophosphorylation induces autoactivation and a decrease in the Src homology 2 domain accessibility of the Lyn protein kinase.
Sotirellis N; Johnson TM; Hibbs ML; Stanley IJ; Stanley E; Dunn AR; Cheng HC
J Biol Chem; 1995 Dec; 270(50):29773-80. PubMed ID: 8530369
[TBL] [Abstract][Full Text] [Related]
16. Identification of efficient pentapeptide substrates for the tyrosine kinase pp60c-src.
Nair SA; Kim MH; Warren SD; Choi S; Songyang Z; Cantley LC; Hangauer DG
J Med Chem; 1995 Oct; 38(21):4276-83. PubMed ID: 7473555
[TBL] [Abstract][Full Text] [Related]
17. Linear and cyclic synthetic peptides related to the main autophosphorylation site of the Src tyrosine kinases as substrates and inhibitors of Lyn.
Ruzza P; Calderan A; Filippi B; Biondi B; Deana AD; Cesaro L; Pinna LA; Borin G
Int J Pept Protein Res; 1995 Jun; 45(6):529-39. PubMed ID: 7558583
[TBL] [Abstract][Full Text] [Related]
18. Design of tetrapeptide ligands as inhibitors of the Src SH2 domain.
Nam NH; Pitts RL; Sun G; Sardari S; Tiemo A; Xie M; Yan B; Parang K
Bioorg Med Chem; 2004 Feb; 12(4):779-87. PubMed ID: 14759738
[TBL] [Abstract][Full Text] [Related]
19. Solution structure of the human pp60c-src SH2 domain complexed with a phosphorylated tyrosine pentapeptide.
Xu RX; Word JM; Davis DG; Rink MJ; Willard DH; Gampe RT
Biochemistry; 1995 Feb; 34(7):2107-21. PubMed ID: 7532003
[TBL] [Abstract][Full Text] [Related]
20. Involvement of pp60c-src with two major signaling pathways in human breast cancer.
Luttrell DK; Lee A; Lansing TJ; Crosby RM; Jung KD; Willard D; Luther M; Rodriguez M; Berman J; Gilmer TM
Proc Natl Acad Sci U S A; 1994 Jan; 91(1):83-7. PubMed ID: 7506422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
